Dr. Christina Camell's lab at the University of Minnesota studies how aging affects the immune response to infections like sepsis, particularly focusing on adipose tissue, which is a type of fat tissue. They explore how inflammatory changes in this tissue contribute to older individuals being more susceptible to severe infections. Through their research, they aim to identify new ways to improve treatment and outcomes for elderly patients suffering from sepsis.

David D. Thomas's lab at the University of Minnesota focuses on developing new drugs to treat skeletal muscle disorders by targeting the regulation of calcium within muscle cells. The team uses innovative fluorescent biosensors to identify small molecules that can correct dysfunctional calcium channels and pumps in muscle tissue. Their research aims to improve therapies for myopathies and other related diseases.

Dr. James M. Ervasti's lab focuses on understanding dystrophin and its role in muscle health, particularly in the context of muscular dystrophies such as Duchenne and Becker. Through innovative animal models and advanced techniques, the lab investigates how dystrophin interacts with microtubules and how its absence contributes to disease. The research aims to identify therapeutic strategies that could effectively replace dystrophin with miniaturized variants.

Dr. Gianluigi Veglia's lab at the University of Minnesota focuses on understanding the molecular basis of diseases linked to mutations in the PRKACA gene, which is crucial for regulating various cellular processes. By studying how specific mutations affect the function of protein kinase A (PKA-C), the lab aims to uncover mechanisms that may lead to conditions like Cushing's syndrome and certain types of cancer. They employ advanced techniques to analyze protein behavior in hopes of finding targeted therapies to correct these dysfunctions.

Dr. Hideki Aihara's lab at the University of Minnesota focuses on understanding how viruses replicate and invade host cells. By studying the molecular structures of various viruses, including retroviruses like the Human T-cell Leukemia virus and coronaviruses, the lab aims to uncover mechanisms that could lead to new antiviral treatments. The research also explores gene delivery methods, which can be helpful in both therapy and research applications.